Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Published Erratum
. 2016 Jul 7;11(1):92.
doi: 10.1186/s13023-016-0463-6.

Erratum to: An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A

Shahram Attarian  1 , Jean-Michel Vallat  2 , Laurent Magy  2 , Benoît Funalot  2 , Pierre-Marie Gonnaud  3 , Arnaud Lacour  4 , Yann Péréon  5 , Odile Dubourg  6 , Jean Pouget  1 , Joëlle Micallef  7 , Jérôme Franques  1 , Marie-Noëlle Lefebvre  7 , Karima Ghorab  2 , Mahmoud Al-Moussawi  3 , Vincent Tiffreau  4 , Marguerite Preudhomme  4 , Armelle Magot  5 , Laurène Leclair-Visonneau  4 , Tanya Stojkovic  6 , Laura Bossi  8 , Philippe Lehert  9   10 , Walter Gilbert  11 , Viviane Bertrand  12 , Jonas Mandel  12 , Aude Milet  12 , Rodolphe Hajj  12 , Lamia Boudiaf  12 , Catherine Scart-Grès  12 , Serguei Nabirotchkin  12 , Mickael Guedj  12 , Ilya Chumakov  12 , Daniel Cohen  13
Affiliations
Published Erratum

Erratum to: An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A

Shahram Attarian et al. Orphanet J Rare Dis. .
No abstract available

PubMed Disclaimer

Figures

Fig. 4
Fig. 4
Response to PXT3003 on clinical scales (Full Analysis Set, n = 80). Mean % (s.e.m.) of improvement from baseline per group at 12 months for CMTNS (a) and ONLS (b). Sample sizes: Placebo (n = 19), LD (n = 21), ID (n = 21), HD (n = 19)
See this image and copyright information in PMC

Erratum for

References

    1. Attarian S, Vallat JM, Magy L, Funalot B, Gonnaud PM, Lacour A, Péréon Y, Dubourg O, Pouget J, Micallef J, Franques J, Lefebvre MN, Ghorab K, Al-Moussawi M, Tiffreau V, Preudhomme M, Magot A, Leclair-Visonneau L, Stojkovic T, Bossi L, Lehert P, Gilbert W, Bertrand V, Mandel J, Milet A, Hajj R, Boudiaf L, Scart-Grès C, Nabirotchkin S, Guedj M, Chumakov I, Cohen D. An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A. Orphanet J Rare Dis. 2014;9:199. doi: 10.1186/s13023-014-0199-0. - DOI - PMC - PubMed

Publication types

LinkOut - more resources